Literature DB >> 22375163

Diabetes patients and non-diabetic patients intensive care unit and hospital mortality risks associated with sepsis.

Chandler J Tayek1, John A Tayek.   

Abstract

AIM: To compare mortality risks associated with known diabetic patients to hyperglycemic non-diabetic patients.
METHODS: PubMed data base was searched for patients with sepsis, bacteremia, mortality and diabetes. Articles that also identified new onset hyperglycemia (NOH) (fasting blood glucose > 125 mg/dL or random blood glucose > 199 mg/dL) were identified and reviewed. Nine studies were evaluated with regards to hyperglycemia and hospital mortality and five of the nine were summarized with regards to intensive care unit (ICU) mortality.
RESULTS: Historically hyperglycemia has been believed to be equally harmful in known diabetic patients and non-diabetics patients admitted to the hospital. Unexpectedly, having a history of diabetes when admitted to the hospital was associated with a reduced risk of hospital mortality. Approximately 17% of patients admitted to hospital have NOH and 24% have diabetes mellitus. Hospital mortality was significantly increased in all nine studies of patients with NOH as compared to known diabetic patients (26.7% ± 3.4% vs 12.5% ± 3.4%, P < 0.05; analysis of variance). Unadjusted ICU mortality was evaluated in five studies and was more than doubled for those patients with NOH as compared to known diabetic patients (25.3% ± 3.3% vs 12.8% ± 2.6%, P < 0.05) despite having similar blood glucose concentrations. Most importantly, having NOH was associated with an increased ICU and a 2.7-fold increase in hospital mortality when compared to hyperglycemic diabetic patients. The mortality benefit of being diabetic is unclear but may have to do with adaptation to hyperglycemia over time. Having a history of diabetes mellitus and prior episodes of hyperglycemia may provide time for the immune system to adapt to hyperglycemia and result in a reduced mortality risk. Understanding why diabetic patients have a lower than expected hospital mortality rate even with bacteremia or acute respiratory distress syndrome needs further study.
CONCLUSION: Having hyperglycemia without a history of previous diabetes mellitus is a major independent risk factor for ICU and hospital mortality.

Entities:  

Keywords:  Bacteremia; Diabetes; Hospital mortality; Intensive care unit mortality; Sepsis

Year:  2012        PMID: 22375163      PMCID: PMC3284518          DOI: 10.4239/wjd.v3.i2.29

Source DB:  PubMed          Journal:  World J Diabetes        ISSN: 1948-9358


  31 in total

1.  The effect of age on the development and outcome of adult sepsis.

Authors:  Greg S Martin; David M Mannino; Marc Moss
Journal:  Crit Care Med       Date:  2006-01       Impact factor: 7.598

2.  Hyperglycemia is associated with adverse outcomes in patients receiving total parenteral nutrition.

Authors:  N Wah Cheung; Brett Napier; Cathy Zaccaria; John P Fletcher
Journal:  Diabetes Care       Date:  2005-10       Impact factor: 19.112

3.  Statin therapy is associated with fewer deaths in patients with bacteraemia.

Authors:  Peter Kruger; Kenneth Fitzsimmons; David Cook; Mark Jones; Graeme Nimmo
Journal:  Intensive Care Med       Date:  2005-11-10       Impact factor: 17.440

4.  Bacteraemia in the elderly: predictors of outcome in an urban teaching hospital.

Authors:  Benjamin M Greenberg; Robert L Atmar; Charles E Stager; Stephen B Greenberg
Journal:  J Infect       Date:  2005-05       Impact factor: 6.072

5.  Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults.

Authors:  Elizabeth Selvin; Michael W Steffes; Hong Zhu; Kunihiro Matsushita; Lynne Wagenknecht; James Pankow; Josef Coresh; Frederick L Brancati
Journal:  N Engl J Med       Date:  2010-03-04       Impact factor: 91.245

6.  Hyperglycemia and mortality in elderly patients with Staphylococcus aureus bacteremia.

Authors:  Mazen S Bader
Journal:  South Med J       Date:  2007-03       Impact factor: 0.954

7.  Glycemic control, diabetic status, and mortality in a heterogeneous population of critically ill patients before and during the era of intensive glycemic management: six and one-half years experience at a university-affiliated community hospital.

Authors:  James S Krinsley
Journal:  Semin Thorac Cardiovasc Surg       Date:  2006

8.  The relationship between admission blood glucose levels and hospital mortality.

Authors:  N W Cheung; S Li; G Ma; R Crampton
Journal:  Diabetologia       Date:  2008-04-16       Impact factor: 10.122

9.  Role of calcium channel blockers in diabetic renal transplant patients: preliminary observations on protection from sepsis.

Authors:  L A Weinrauch; J A D'Elia; R E Gleason; D Shaffer; A P Monaco
Journal:  Clin Nephrol       Date:  1995-09       Impact factor: 0.975

10.  Acute hyperglycaemia disturbs cardiac repolarization in Type 1 diabetes.

Authors:  D Gordin; C Forsblom; M Rönnback; P-H Groop
Journal:  Diabet Med       Date:  2008-01       Impact factor: 4.359

View more
  5 in total

Review 1.  Blood glucose measurement in the intensive care unit: what is the best method?

Authors:  Huong T Le; Neil S Harris; Abby J Estilong; Arvid Olson; Mark J Rice
Journal:  J Diabetes Sci Technol       Date:  2013-03-01

2.  Diagnosis trajectories of prior multi-morbidity predict sepsis mortality.

Authors:  Mette K Beck; Anders Boeck Jensen; Annelaura Bach Nielsen; Anders Perner; Pope L Moseley; Søren Brunak
Journal:  Sci Rep       Date:  2016-11-04       Impact factor: 4.379

3.  Some questions about preadmission metformin use and mortality in patients with sepsis and diabetes mellitus.

Authors:  Jiarong Ye; Qianrong Liang; Xiaotu Xi
Journal:  Crit Care       Date:  2019-03-25       Impact factor: 9.097

Review 4.  Blood glucose levels should be considered as a new vital sign indicative of prognosis during hospitalization.

Authors:  Jothydev Kesavadev; Anoop Misra; Banshi Saboo; S R Aravind; Akhtar Hussain; Leszek Czupryniak; Itamar Raz
Journal:  Diabetes Metab Syndr       Date:  2021-01-02

Review 5.  Type 2 diabetes mellitus and sepsis: state of the art, certainties and missing evidence.

Authors:  Elisa Costantini; Massimiliano Carlin; Massimo Porta; Maria Felice Brizzi
Journal:  Acta Diabetol       Date:  2021-05-10       Impact factor: 4.280

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.